LSV Asset Management’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-16,400
Closed -$2.47M 839
2024
Q4
$2.47M Hold
16,400
0.01% 543
2024
Q3
$2.55M Sell
16,400
-85,358
-84% -$12.7M 0.01% 560
2024
Q2
$13.9M Sell
101,758
-213,562
-68% -$29.2M 0.03% 388
2024
Q1
$42M Sell
315,320
-59,450
-16% -$7.71M 0.09% 236
2023
Q4
$51.7M Sell
374,770
-605,652
-62% -$79.6M 0.11% 215
2023
Q3
$119M Sell
980,422
-141,535
-13% -$18.9M 0.28% 114
2023
Q2
$158M Sell
1,121,957
-100,700
-8% -$13.9M 0.35% 95
2023
Q1
$173M Sell
1,222,657
-14,485
-1% -$2.07M 0.39% 90
2022
Q4
$194M Sell
1,237,142
-56,425
-4% -$8.11M 0.43% 76
2022
Q3
$159M Sell
1,293,567
-43,700
-3% -$5.76M 0.37% 88
2022
Q2
$178M Sell
1,337,267
-56,500
-4% -$7.7M 0.38% 86
2022
Q1
$191M Buy
1,393,767
+22,600
+2% +$3.15M 0.35% 94
2021
Q4
$237M Buy
1,371,167
+109,230
+9% +$16.6M 0.42% 76
2021
Q3
$183M Buy
1,261,937
+79,985
+7% +$11.7M 0.33% 96
2021
Q2
$156M Sell
1,181,952
-3,540
-0.3% -$463K 0.27% 121
2021
Q1
$152M Sell
1,185,492
-58,300
-5% -$7.18M 0.26% 119
2020
Q4
$148M Buy
1,243,792
+390,100
+46% +$47.6M 0.27% 119
2020
Q3
$97.7M Sell
853,692
-12,260
-1% -$1.45M 0.2% 133
2020
Q2
$98.7M Buy
865,952
+94,000
+12% +$9.97M 0.2% 128
2020
Q1
$62M Buy
771,952
+46,200
+6% +$4.78M 0.15% 169
2019
Q4
$77.5M Sell
725,752
-30,252
-4% -$3.15M 0.12% 198
2019
Q3
$80.9M Sell
756,004
-42,900
-5% -$4.4M 0.13% 189
2019
Q2
$81.3M Sell
798,904
-2,200
-0.3% -$211K 0.13% 188
2019
Q1
$72M Sell
801,104
-6,099
-0.8% -$528K 0.12% 203
2018
Q4
$67.2M Buy
807,203
+36,199
+5% +$3.39M 0.12% 190
2018
Q3
$83.2M Sell
771,004
-5,196
-0.7% -$570K 0.12% 191
2018
Q2
$85.3M Buy
776,200
+38,200
+5% +$3.98M 0.13% 189
2018
Q1
$74M Sell
738,000
-424,945
-37% -$43.5M 0.12% 197
2017
Q4
$115M Sell
1,162,945
-273,005
-19% -$25.9M 0.18% 154
2017
Q3
$134M Sell
1,435,950
-177,400
-11% -$18.8M 0.22% 129
2017
Q2
$179M Sell
1,613,350
-1,536,959
-49% -$163M 0.32% 95
2017
Q1
$309M Sell
3,150,309
-216,050
-6% -$20.6M 0.56% 48
2016
Q4
$309M Sell
3,366,359
-119,385
-3% -$10.3M 0.57% 45
2016
Q3
$295M Sell
3,485,744
-46,900
-1% -$3.94M 0.58% 44
2016
Q2
$288M Buy
3,532,644
+44,719
+1% +$3.41M 0.59% 43
2016
Q1
$249M Buy
3,487,925
+364,450
+12% +$24.4M 0.52% 57
2015
Q4
$222M Sell
3,123,475
-41,825
-1% -$2.81M 0.48% 68
2015
Q3
$195M Buy
3,165,300
+979,800
+45% +$68.5M 0.44% 79
2015
Q2
$158M Buy
2,185,500
+649,000
+42% +$47.9M 0.33% 104
2015
Q1
$118M Buy
1,536,500
+161,085
+12% +$11.5M 0.25% 123
2014
Q4
$92.2M Buy
1,375,415
+79,675
+6% +$5.03M 0.19% 132
2014
Q3
$78.6M Buy
1,295,740
+168,500
+15% +$10.4M 0.17% 136
2014
Q2
$66.2M Buy
1,127,240
+839,121
+291% +$49.1M 0.15% 141
2014
Q1
$16.7M Buy
288,119
+229,219
+389% +$12.3M 0.04% 284
2013
Q4
$3.15M Hold
58,900
0.01% 511
2013
Q3
$3.64M Buy
58,900
+24,800
+73% +$1.48M 0.01% 495
2013
Q2
$2.07M Buy
+34,100
New +$2.03M 0.01% 562

Other funds holding DGX

LSV Asset Management's DGX Position: Q1 2025 in Review

LSV Asset Management sold out of Quest Diagnostics (DGX) in Q1 2025, closing a stake of 16,400 shares — an estimated $2.47M sold.

LSV Asset Management first reported a position in DGX in Q2 2013 and held it in 47 quarters. The position peaked at $309M in Q4 2016. 967 funds tracked by Wall St. Rank hold DGX as of Q1 2025.

  • LSV Asset Management reported no remaining Quest Diagnostics position as of Q1 2025 after selling out during the quarter.
  • LSV Asset Management sold 16,400 Quest Diagnostics shares in Q1 2025, an estimated $2.47M.
  • LSV Asset Management first reported a position in Quest Diagnostics in Q2 2013 and held it in 47 quarters.
  • LSV Asset Management's Quest Diagnostics position peaked at $309M in Q4 2016.
  • 967 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2025.

Based on LSV Asset Management's 13F filing for Q1 2025, filed 9 May 2025.